News/Virtual Assistant News Desk

Bone Health and Osteoporosis Clinic Virtual Assistants: Reclast Infusion Prior Auth, Fracture Liaison Documentation, and Supplement Tracking

Virtual Assistant News Desk·

Osteoporosis affects an estimated 10 million Americans, and another 44 million have low bone density placing them at elevated fracture risk. Despite highly effective treatment options, the National Osteoporosis Foundation reports that fewer than 25% of women who suffer a fragility fracture receive appropriate pharmacologic treatment within the following year — a gap that is partly clinical but largely administrative.

Bone health and osteoporosis clinics addressing this gap face a specific set of administrative challenges: DEXA scan scheduling with correct billing parameters, bisphosphonate infusion authorization, fracture liaison service (FLS) documentation, and the longitudinal tracking of supplement adherence. Virtual assistants (VAs) trained in bone health workflows are helping these clinics build the systematic infrastructure that translates good clinical intent into consistent patient outcomes.

Reclast Infusion Prior Authorization: Annual Coverage, Annual Battle

Zoledronic acid (Reclast) is an annual intravenous bisphosphonate indicated for the treatment of postmenopausal osteoporosis and glucocorticoid-induced osteoporosis. It is highly effective and convenient given its once-yearly dosing — but its prior authorization process is reliably time-consuming.

Most commercial payers require documentation of DEXA T-score ≤-2.5 (or ≤-1.5 with a fragility fracture history), evidence that oral bisphosphonates were contraindicated or previously tried, creatinine clearance documentation (Reclast is contraindicated with CrCl <35 mL/min), and the prescribing physician's attestation of osteoporosis diagnosis.

A VA managing Reclast prior auth builds payer-specific checklists, compiles the required documentation from the EHR, submits through payer portals or by fax, tracks authorization expiration dates (annual renewals must be initiated 4–6 weeks before the planned infusion date), and manages denials through the appeals process. Without this structured follow-through, patients miss their infusion window and fracture risk goes unaddressed for another year.

DEXA Scan Scheduling: Authorization, Timing, and Coding Accuracy

Dual-energy X-ray absorptiometry (DEXA) is the standard imaging modality for bone density assessment, and it generates its own administrative workflow. Medicare covers DEXA every 24 months for qualifying patients; some commercial plans have different intervals. For patients with osteoporosis on treatment, monitoring frequency may be supported by clinical indication outside standard coverage intervals.

A VA managing DEXA scheduling verifies insurance eligibility and coverage interval, submits prior authorization where required, books the scan at a facility that returns reports to the referring practice, and ensures the order specifies the appropriate sites (lumbar spine and bilateral hip for standard monitoring) with correct ICD-10 coding (M81.0 for postmenopausal osteoporosis; Z87.310 for personal history of fragility fracture).

When DEXA results arrive, the VA routes T-score and Z-score findings to the clinical team with comparison to prior studies and flags values that cross treatment initiation thresholds per NOF and ISCD guidelines.

Fracture Liaison Service Documentation

Fracture liaison services (FLS) are systematic programs that identify fragility fracture patients in hospital or emergency settings and coordinate their transition to osteoporosis evaluation and treatment. FLS programs have been shown to reduce secondary fracture rates by 40–60%, but their effectiveness depends entirely on the administrative infrastructure behind them.

FLS documentation involves tracking patients referred from orthopedics or the emergency department, ensuring DEXA is ordered, confirming that the patient's primary care or endocrinology team has been engaged, documenting the FRAX fracture risk calculation, and recording treatment initiation. A VA managing the FLS caseload maintains the tracking database, ensures no referred patient falls through the follow-up gap, and generates reports for the FLS program coordinator on enrollment and treatment rates.

Vitamin D and Calcium Supplement Adherence Tracking

Long-term vitamin D and calcium supplementation is foundational to osteoporosis management, but adherence tracking is rarely systematized. Many practices rely on patient self-report at each visit without a consistent documentation structure, making it difficult to assess whether supplementation gaps are contributing to treatment non-response.

A VA supporting supplement adherence tracking documents current regimen at each encounter, sends periodic patient outreach to confirm adherence, flags patients with 25-hydroxyvitamin D levels below target (typically 30–50 ng/mL for osteoporosis patients), and notes medication interactions (calcium with levothyroxine, for example) for physician review.

Bone health programs that are serious about closing the osteoporosis treatment gap need administrative infrastructure that matches their clinical commitment. Stealth Agents provides VAs trained in bone health and osteoporosis workflows, giving practices the systematic support layer that prevents patients from slipping through the cracks between DEXA and treatment.

Sources